# FDA Inspection 1266877 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. - April 04, 2025

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd/97e536cd-82c5-4cb4-a072-9ea867b4e9cc
Source feed: FDA_Inspections

> FDA Inspection 1266877 for Jiangsu Hengrui Pharmaceuticals Co., Ltd. on April 04, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266877
- Company Name: Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Inspection Date: 2025-04-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266877 - 2025-04-04](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd/45baa0c0-8a4e-43c4-9343-d01f00fa5358)
- [FDA Inspection 1233962 - 2024-01-19](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd/4aaf57a6-f614-4bcb-bdf9-b2d5fab220f0)

Company: https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd/d8430568-25ba-4cb0-a549-75fa7caf0a45

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c